41 related articles for article (PubMed ID: 35297009)
1. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
Wu Y; Han Y; Li Q; Zhang P; Yuan P; Luo Y; Fan Y; Chen S; Cai R; Li Q; Xu H; Wang Y; Ma F; Wang J; Xu B
Breast Cancer Res Treat; 2022 Jun; 193(2):381-392. PubMed ID: 35297009
[TBL] [Abstract][Full Text] [Related]
2. The correlation study between TOP2A gene expression in circulating tumor cells and chemotherapeutic drug resistance of patients with breast cancer.
Ye JH; Yu J; Huang MY; Mo YM
Breast Cancer; 2024 May; 31(3):417-425. PubMed ID: 38561479
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study.
Tashima R; Nishimura R; Osako T; Nishiyama Y; Okumura Y; Nakano M; Fujisue M; Toyozumi Y; Arima N
PLoS One; 2015; 10(7):e0119565. PubMed ID: 26177501
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.
Ip JC; Pang TC; Glover AR; Soon P; Zhao JT; Clarke S; Robinson BG; Gill AJ; Sidhu SB
Oncologist; 2015 Mar; 20(3):247-56. PubMed ID: 25657202
[TBL] [Abstract][Full Text] [Related]
5. A multicenter study of the clinicopathological characteristics and a risk prediction model of early-stage breast cancer with hormone receptor-positive/human epidermal growth factor receptor 2-low expression.
Xin L; Wu Q; Zhan C; Qin H; Xiang H; Gao M; Duan X; Liu Y; Ye J; ;
Chin Med J (Engl); 2023 Dec; 136(24):2967-2973. PubMed ID: 37822006
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C
BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997
[TBL] [Abstract][Full Text] [Related]
7. Prognostic model of ER-positive, HER2-negative breast cancer predicted by clinically relevant indicators.
Song X; Wang P; Feng R; Chetry M; Li E; Wu X; Liu Z; Liao S; Lin J
Clin Transl Oncol; 2024 Feb; 26(2):389-397. PubMed ID: 37713046
[TBL] [Abstract][Full Text] [Related]
8. Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis.
Ren L; Liu J; Gou K; Xing C
J Cancer; 2018; 9(12):2082-2092. PubMed ID: 29937926
[No Abstract] [Full Text] [Related]
9. The Potential Value of Ki-67 in Prognostic Classification in Early Low-Risk Endometrial Cancer.
Jia M; Pi J; Zou J; Feng M; Chen H; Lin C; Yang S; Xiao X
Cancer Control; 2023; 30():10732748231206929. PubMed ID: 37924202
[TBL] [Abstract][Full Text] [Related]
10. Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer.
Nuncia-Cantarero M; Martinez-Canales S; Andrés-Pretel F; Santpere G; Ocaña A; Galan-Moya EM
Breast Cancer Res Treat; 2018 Apr; 168(3):613-623. PubMed ID: 29330624
[TBL] [Abstract][Full Text] [Related]
11. The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients.
Ma Q; Liu YB; She T; Liu XL
Breast Cancer (Dove Med Press); 2024; 16():117-126. PubMed ID: 38476641
[TBL] [Abstract][Full Text] [Related]
12. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients.
Hao H; Yang L; Wang B; Sang Y; Liu X
Open Life Sci; 2023; 18(1):20220784. PubMed ID: 38027223
[TBL] [Abstract][Full Text] [Related]
13. High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis.
Cai H; Shao B; Zhou Y; Chen Z
Oncol Lett; 2020 Nov; 20(5):232. PubMed ID: 32968454
[TBL] [Abstract][Full Text] [Related]
14. Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study.
Wrzeszcz K; Kwiatkowska K; Rhone P; Formanowicz D; Kruszewski S; Ruszkowska-Ciastek B
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610786
[No Abstract] [Full Text] [Related]
15. Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients.
Yang Y; Min A; Lee KH; Ryu HS; Kim TY; Woo GU; Suh KJ; Lee DW; Lee HB; Moon HG; Han W; Park IA; Noh DY; Im SA
J Breast Cancer; 2020 Apr; 23(2):182-193. PubMed ID: 32395377
[TBL] [Abstract][Full Text] [Related]
16. RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
Behrens A; Wurmthaler L; Heindl F; Gass P; Häberle L; Volz B; Hack CC; Emons J; Erber R; Hartmann A; Beckmann MW; Ruebner M; Dougall WC; Press MF; Fasching PA; Huebner H
Geburtshilfe Frauenheilkd; 2024 Jan; 84(1):77-85. PubMed ID: 38178900
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of P53 index in predicting the recurrence of early low-risk endometrial cancer.
Çakır İ; Gülseren V; Aköz G; Şahin Z; Sever B; Çakır ZE; Sancı M; Kuru O; Özdemir İA; Güngördük K
J Obstet Gynaecol Res; 2023 Oct; 49(10):2487-2493. PubMed ID: 37497887
[TBL] [Abstract][Full Text] [Related]
18. Sprouty 1 predicts prognosis in human epithelial ovarian cancer.
Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
Am J Cancer Res; 2015; 5(4):1531-41. PubMed ID: 26101716
[TBL] [Abstract][Full Text] [Related]
19. Refining breast cancer biomarker discovery and drug targeting through an advanced data-driven approach.
Rakhshaninejad M; Fathian M; Shirkoohi R; Barzinpour F; Gandomi AH
BMC Bioinformatics; 2024 Jan; 25(1):33. PubMed ID: 38253993
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive atlas of epigenetic regulators reveals tissue-specific epigenetic regulation patterns.
Wang J; Shi A; Lyu J
Epigenetics; 2023 Dec; 18(1):2139067. PubMed ID: 36305095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
